Joseph E. Kiss

Joseph E. Kiss

Auto-generated profile, based on publicly available information

Joseph E. Kiss

Institute for Transfusion Medicine, Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2015 in JAMA
Verified
Journal Article
Open access
PDF file
JKJoseph E Kiss
Joseph E Kiss
DBDonald Brambilla
Donald Brambilla
SGSimone A Glynn
Simone A Glynn
AMAlan E Mast
Alan E Mast
BSBryan R Spencer
Bryan R Spencer
N(National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study–III (REDS-III)
National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study–III (REDS-III)
It is estimated that 25% to 35% of blood donors become iron depleted from regular blood donation.1,2 In 2011, 9.2 million individuals in the United States donated 15.7 million units of red blood cells.3 Overall, 6.7% of these donors were deferred for not meeting the minimum capillary hemoglobin standard of 12.5 g/dL. Low hemoglobin, a late consequence of iron depletion, represents the single largest category of blood donor deferral and is more prevalent in women. Hemoglobin level and iron status are getting renewed attention as a donor safety issue based on increasing evidence that iron depletion is associated with fatigue,4 decreased exercise capacity,5 neurocognitive changes,6,7 pica, and restless legs syndrome.8,9

1 July 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
GPGrier Page
Grier Page
TKTamir Kanias
Tamir Kanias
YGYuelong J. Guo
Yuelong J. Guo
MLMarion C. Lanteri
Marion C. Lanteri
XZXu Zhang
Xu Zhang
MGMark T. Gladwin
Mark T. Gladwin
Background. The evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease. Methods. We sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,406 African Americans, 1,306 Asians, and 945 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis. Results. GWAS revealed 27 significant loci (P < 5 × 10–8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/band 3. GWAS of oxidative hemolysis identified variants in genes encoding antioxidant enzymes, including GLRX, GPX4, G6PD, and SEC14L4 (Golgi-transport protein). Genome-wide significant loci were also tested for association with the severity of steady-state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1, and SEC14L4. Conclusions. Many of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases. Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.

16 May 2018 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
JKJoseph E. Kiss
Joseph E. Kiss
RVRalph R. Vassallo
Ralph R. Vassallo

1 March 2015 in Clinics In Laboratory Medicine
Verified
Journal Article
Closed access
JKJoseph E. Kiss
Joseph E. Kiss

26 April 2013 in Transfusion
Verified
Journal Article
Closed access
PDF file
JKJoseph E. Kiss
Joseph E. Kiss
WSWhitney R. Steele
Whitney R. Steele
DWDavid J. Wright
David J. Wright
AMAlan E. Mast
Alan E. Mast
PCPatricia M. Carey
Patricia M. Carey
N(NHLBI Retrovirus Epidemiology Donor Study‐II (REDS‐II)
NHLBI Retrovirus Epidemiology Donor Study‐II (REDS‐II)

9 January 2010 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
JKJoseph E. Kiss
Joseph E. Kiss